Enanta Pharmaceuticals/ US29251M1062 /
| 2024-04-15 9:59:50 PM | Chg. -0.32 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 16.14USD | -1.94% | 7,661 Turnover: 124,695.48 |
-Bid Size: - | -Ask Size: - | 16.56 | 16.09 |
GlobeNewswire
2020-07-08
Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors
GlobeNewswire
2019-04-10
Market Trends Toward New Normal in Tesla, Zuora, SunOpta, Internap, Enanta Pharmaceuticals, and Hilt...
GlobeNewswire
2019-02-15
Factors of Influence in 2019, Key Indicators and Opportunity within BCE, Nektar Therapeutics, Hormel...
GlobeNewswire
2018-09-25
Recent Analysis Shows Enanta Pharmaceuticals, Multi-Color, Otter Tail, Franklin Resources, CubeSmart...
GlobeNewswire
2018-08-07
Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis 2018-2026: Hot Targets, Mechanisms & Therapies
GlobeNewswire
2018-06-26
Antibiotic Resistance (2018-2023) Global Market Report - Search for Alternatives to Antibiotics Crea...
GlobeNewswire
2018-05-29
Factors of Influence in 2018, Key Indicators and Opportunity within Assembly Biosciences, MGP Ingred...
GlobeNewswire
2018-04-04
Report: Developing Opportunities within Enanta Pharmaceuticals, ServisFirst Bancshares, Lion Biotech...
GlobeNewswire
2018-02-06
Recent Analysis Shows Daktronics, Haynes International, Envestnet, Calpine, Enanta Pharmaceuticals, ...
GlobeNewswire
2017-08-17
Global Deuterated Drugs Formulations Therapeutics Strategies & Markets 2017-2024
